Physician profile
Erik E Alexander
NPI 1073590014
$7,268.92
in general payments reported to CMS, 2019-2025
40 companies · $863 in 2025
The $863 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,522 · 2020: $244 · 2021: $498 · 2022: $963 · 2023: $1,707 · 2024: $1,471 · 2025: $863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,041.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,286.68 | 2019-2020 | |
| Teleflex LLC | $556.89 | 2021-2025 | Urolift, Barrigel |
| Abbvie INC. | $534.57 | 2021-2025 | Avycaz, Lupron Depot, Botox |
| Coloplast Corp | $468.76 | 2019-2024 | Titan, Speedicath, Luja Coude |
| Progenics Pharmaceuticals, INC. | $401.17 | 2022-2025 | Pylarify |
| Dendreon Pharmaceuticals LLC | $371.28 | 2019-2025 | Provenge |
| Boston Scientific Corporation | $318.36 | 2019-2024 | Ams 700, Ams 700 Cxr Rte Kit, Rezum Generator |
| Pfizer INC. | $293.72 | 2019-2025 | |
| Antares Pharma, INC. | $282.25 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Janssen Biotech, INC. | $277.09 | 2022-2025 | Carvykti, Rybrevant, Erleada |
| Blue Earth Diagnostics | $232.38 | 2019-2025 | Posluma |
| C. R. Bard, INC. & Subsidiaries | $207.29 | 2020-2025 | Bard Urinary Drainage Bag |
| Astellas Pharma US INC | $188.73 | 2021-2025 | Myrbetriq, Xtandi |
| Myriad Genetic Laboratories, INC. | $186.63 | 2023-2024 | Prolaris |
| Halozyme INC | $171.73 | 2023 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $163.07 | 2022-2024 | Keytruda, Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $152.62 | 2022-2025 | |
| Endo Pharmaceuticals INC. | $109.41 | 2019-2024 | Xiaflex, Aveed, Edex |
| 180 Medical, INC. | $109.00 | 2021-2025 | Gentlecath Glide, Gentlecath |
| Novartis Pharmaceuticals Corporation | $103.97 | 2024-2025 | |
| Axonics, INC. | $96.48 | 2022-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $79.81 | 2023-2025 | Gemtesa |
| Olympus America INC. | $74.31 | 2022-2025 | Itind System |
| Endo USA, INC. | $71.89 | 2024-2025 | Xiaflex, Aveed |
| Alnylam Pharmaceuticals INC. | $69.13 | 2023 | Givlaari |
| Ambu INC. | $63.12 | 2023-2024 | |
| Urogen Pharma, INC. | $49.79 | 2022-2025 | |
| Tolmar, INC. | $45.11 | 2023-2024 | |
| Tolmar Pharmaceuticals, INC. | $44.34 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $43.24 | 2023-2024 | Lynparza |
| Ferring Pharmaceuticals INC. | $33.20 | 2024-2025 | Adstiladrin |
| Vertex Pharmaceuticals Incorporated | $29.12 | 2025 | |
| Davol INC. | $28.28 | 2024 | Channel Drain |
| Abbott Laboratories | $22.33 | 2021 | |
| Sun Pharmaceutical Industries INC. | $21.21 | 2024 | |
| Tempus Ai, INC | $20.94 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $19.24 | 2024 | Simlandi |
| Convatec INC. | $16.30 | 2021 | |
| Amgen INC. | $13.33 | 2021 | |
| Accord Healthcare, INC. | $12.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.